EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    2.4.2.30 | Infections |
112058 |
Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 2.4.2.30 | Pseudomonas Infections |
112058 |
Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 2.4.2.30 | Carcinoma, Ehrlich Tumor |
188648 |
Purification of poly(ADP-ribose) polymerase from Ehrlich ascites tumor cells by chromatography on DNA-agarose. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 2.4.2.30 | Neoplasms |
188648 |
Purification of poly(ADP-ribose) polymerase from Ehrlich ascites tumor cells by chromatography on DNA-agarose. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 2.4.2.30 | Diphtheria |
210453 |
Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. |
unassigned |
0 |
| 2.4.2.30 | Carcinoma, Ehrlich Tumor |
211029 |
Poly(ADP-ribose) polymerase from Ehrlich ascites tumor cells. Properties of the purified polymerase. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 2.4.2.30 | Neoplasms |
211029 |
Poly(ADP-ribose) polymerase from Ehrlich ascites tumor cells. Properties of the purified polymerase. |
diagnostic usage
ongoing research
unassigned |
3
2
0 |
| 2.4.2.30 | Leukemia, Erythroblastic, Acute |
230509 |
Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
4
2
0 |
| 2.4.2.30 | Whooping Cough |
233166 |
Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 2.4.2.30 | Cholera |
1279450 |
Peptidergic modulation of G-protein coupled cyclic-AMP accumulation in the rat caudate nucleus. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
